Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells

Urology

Volumn 51, Issue 1, 1998, Pages 161-167

  Ferrer, Fernando A ^a   Miller, Lauri J ^a   Andrawis, Ramez I ^a   Kurtzman, Scott H ^a   Albertsen, Peter C ^a   Laudone, Vincent P ^a   Kreutzer, Donald L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIOIMMUNOASSAY; TUMOR VASCULARIZATION;

ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LYMPHOKINES; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031938669     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00491-3     Document Type: Article

References (37)

1. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19, 1995.
2. Bigler SA, Deering RE, and Brawer MK: Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 24: 220-226, 1993.
3. Brawer MK, Deering RE, Marianne B, Preston D, and Bigler SA: Predictors of pathologic stage in prostate carcinoma: the role of neovascularity. Cancer 73: 678 -687, 1994.
4. Weidner N: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993.
5. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
6. Fidler IJ, and Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994.
7. Ferrer FA, Miller LJ, Andrawis R, Kurtzman S, Albertsen PA, Laudone VP, and Kruetzer D: Vascular endothelial growth factor (VEGF) expression in human prostate cancer. J Urol 157: 2329-2333, 1997.
8. Dvorak HF, Brown LF, Detmer M, and Dvorak A: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
9. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Ener SG, and Stieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
10. Schadendorf D, Moller A, Algermisssen B, Worm M, Sticherling M, and Czarnctzki BM: 11-8 produced by human malignant melanoma cells is an essential autocrine growth factor. J Immunol 151: 2667-2675, 1993.
11. Cohen RF, Contrino J, Spiro JD, Mann EA, Chen LL, and Kreutzer DL: Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol 121: 202-209, 1995.
12. Smith DR, Polverini PJ, Kunkel SL, Oringer MB, Whyte RI, Burdick MD, Wilke CA, and Stricter RM: Inhibitor of interleukin-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179: 1409-1415, 1994.
13. Gonby P: Medical news and perspectives. J Am Med Assoc 274: 110-111, 1995.
14. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
15. Weinstat-Saslow D, and Steeg PS: Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8: 401-407, 1994.
16. Andrawis R, Nashid NS, Lindquist RR, Fitzgerald J, Albertsen PC, Walzak M, and Kreutzer D: Angiogensis in prostate cancer and benign prostatic hyperplasia (abstract). J Urol 153: 355A, 1996.
17. Schultz GS, and Grant MB: Neovascular growth factors. Eye 5: 170-180, 1991.
18. Hu DE, Hori Y, and Fan TP: Interleukin-8 stimulates angiogenesis in rats. Inflammation 17: 135-143, 1993.
19. Senger DE, Van De Water L, Brown L, Nagy J, Yeo K-T, Berse B, Jackman R, Dvorak A, and Dvorak H: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324, 1993.
20. Senger DR, Galli SJ, Dvorak A, Perruzzi CA, Harvey VS, and Dvorak H: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983.
21. Senger DR, Perruzzi CA, Feder J, and Dvorak H: A highly conserved vascular permeability factor secreted by a variety of human and rodent cell lines. Cancer Res 46: 5629-5632, 1986.
22. Ferrara N, Hainsohn H, Waldec CE, Bunting S, and Thomas GR: The regulation of blood vessel growth by vascular endothelial growth factor. Ann NY Acad Sci 752: 246-256, 1995.
23. Berse BL, Brown L, Van De Water L, and Senger DR: Vascular permeability factor gene is expressed differentially in normal tissues, macrophages and tumors. Mol Biol Cell 3: 211-220, 1992.
24. Plate KH, Breier G, Weich HA, and Risau W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
25. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, and Oldfield EH: Expression of vascular permeability: vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 153-159, 1993.
26. Warren RS, Yan H, Matli MR, Gillet NA, and Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1797, 1995.
27. Zhang HT, Craft P, Scott PA, Ziehe M, Weich HA, Harris AL, and Bickwell R: Enhancement of tumor growth and vascular density by transfection of vascular endothelial growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87: 213-219, 1995.
28. Millauer B, Longhi MP, Plate KH, Shawer LK, Risau W, Ulrich A, and Strawn LM: Dominant-negative inhibition of flk-1 suppresses the growth of many tumor types in-vivo. Cancer Res 56: 1615-1620, 1996.
29. Kurtzman SH, Anderson K, Wang YP, Miller LJ, Burrows GH, and Kreutzer DL: Increased angiogenesis factor expression is associated with negative hormone receptor status in human breast cancer. Surgical Forum 82nd Annual Clinical Congress, 1996, pp 476-478.
30. Jakeman LJ, Winer G, Bennett C, Altar C, and Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89: 244-253, 1992.
31. Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
32. Dinarello CA, and Wolf SM: The role of interleukin-1 in disease. N Engl J Med 328: 106-113, 1993.
33. Frank S, Hubner G, Breier G, Longaker MT, Green-halgh DC, and Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 270: 12607-12613, 1995.
34. Ben-Av P, Crofford LJ, Wilder RL, and Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 372: 83-87, 1995.
35. Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, and Dinarello CA: Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84: 4242-4248, 1994.
36. De AK, Kodys K, Puyana JC, Fudem G, Savoie P, and Miller CL: Elevated IL-8 production by trauma patients is associated with elevated secretion of TNF-alpha. Shock 4: 171-177, 1995.
37. Wilmer JL, and Luster MI: Chemical induction of interleukin-8, a proinflammatory cytokine, in human epidermal keratinocyte cultures and its relation to cytogenetic toxicity. Cell Biol Toxicol 11: 37-50, 1995.